US Earnings Financial Results SEC Filings — August 14, 2026

14-08-2026

SIM Acquisition Corp. I (SIMAU) filed its Form 10-Q for the quarter ended June 30, 2026, reporting net income of $382,174 for Q2 2026, down 83.4% from $2,297,552 in Q2 2025. For the six-month period, net income fell 46.7% to $2,410,573 from $4,520,298. The decline was driven by a sharp drop in interest earned on trust assets ($1.0M vs $2.5M in Q2) and higher general and administrative expenses ($632,248 vs $181,535). The company redeemed $242.2M of Class A ordinary shares during the period, reducing trust account assets from $245.1M to $6.1M, and converted 3.0M Class B shares to Class A shares. A $1.5M working capital promissory note from the sponsor was drawn, and the $10.95M deferred underwriting fee was waived.

• · The company's accumulated deficit improved from $(10,884,932) at December 31, 2025 to $(694,090) at June 30, 2026, primarily due to accretion adjustments.
• · Total assets decreased 97.4% from $245.4M to $6.4M, driven by redemptions.
• · Total liabilities decreased from $11.3M to $1.1M, mainly due to the waiver of the $10.95M deferred underwriting fee.
• · Shareholders' deficit improved from $(10.9M) to $(693,323).
• · Cash used in operating activities was $536,722 in H1 2026 vs $350,916 in H1 2025, a 53% increase in cash burn.
• · Basic and diluted EPS for both redeemable and non-redeemable shares was $0.02 in Q2 2026, down from $0.07 in Q2 2025.

14-08-2026

American Picture House Corp (APHP) filed its 10-Q for the quarter ended June 30, 2026, reporting no revenue for the quarter and a net loss of $71,458, a significant improvement from the $760,628 net loss in the same quarter of 2025. However, the company's cash position deteriorated to zero from $124 at year-end 2025, and total assets fell 12.4% to $1,319,247 while total liabilities rose to $1,795,987, deepening stockholders' deficit to ($476,740) from ($257,547).

• · General and administrative expenses dropped sharply from $750,406 in Q2 2025 to $56,481 in Q2 2026, a 92.5% reduction.
• · Interest expense increased to $12,773 in Q2 2026 from $8,897 in Q2 2025, a 43.6% rise.
• · The company had a cash overdraft of $767 as of June 30, 2026, compared to none at year-end 2025.
• · Produced and licensed content costs surged to $1,175,000 from $300,000, a 291.7% increase, indicating investment in content.
• · Accounts receivable from Collection Service Fees fell to $120,596 from $1,150,000, an 89.5% decline.
• · Net cash provided by financing activities decreased to $51,066 from $245,876, a 79.2% drop, as the company reduced related-party borrowings.
• · The company had no revenue in Q2 2026 or Q2 2025; minimal revenue of $1,220 was recorded in H1 2026 from CAMA.
• · Weighted average shares outstanding increased to 113,563,498 in Q2 2026 from 112,421,303 in Q2 2025.
• · The company's accumulated deficit grew to ($8,069,091) from ($7,826,394) at year-end 2025.

14-08-2026

Cottonwood Communities, Inc. reported a net loss attributable to common stockholders of $9.7M for Q2 2026 and $16.4M for H1 2026, compared to net income of $16.5M and $8.9M in the same periods of 2025. Total revenues grew 22.4% YoY to $47.7M in Q2 and 19.5% to $95.2M in H1, driven by a 23.6% increase in rental and other property revenues. However, the company swung to an operating loss of $3.0M in Q2 (vs. income of $0.5M a year ago) and a $10.2M loss for H1 (vs. income of $1.4M), primarily due to a sharp increase in depreciation and amortization and equity losses from unconsolidated entities. Gains on asset sales provided a partial offset, but the overall performance reflects a mixed quarter with revenue growth overshadowed by higher costs and investment losses.

• · Property management revenues were nearly flat at $1.7M in Q2 2026 vs $1.7M in Q2 2025, and declined 3.7% in H1 2026 to $3.3M from $3.5M.
• · Interest expense increased 6.7% to $19.5M in Q2 2026 from $18.3M in Q2 2025, and was roughly flat at $38.7M for H1 2026 vs $38.4M.
• · Cash and cash equivalents plus restricted cash totaled $98.6M at June 30, 2026, down from $154.8M a year earlier.
• · Net cash provided by operating activities was $1.2M in H1 2026 vs a use of $8.1M in H1 2025.
• · The company completed acquisitions of Orchards at Cherry Creek Apartments and 5 Row Apartments, issuing OP Units valued at $43.6M and $11.4M respectively.
• · Melrose Phase II was deconsolidated, with real estate assets derecognized of $35.5M and a retained interest of $4.3M recorded as an equity method investment.

14-08-2026

Alpha Modus Holdings, Inc. reported a net loss of $2.15M for Q2 2026, an improvement from the $2.79M loss in Q2 2025. For the six months ended June 30, 2026, the net loss widened to $6.17M from $3.10M in the prior year period. Cash increased sharply to $2.00M from $68,000 at year-end 2025, driven by $2.87M in stock sales and $2.00M in convertible note proceeds, but operating cash burn also increased to $2.40M from $1.12M. Total liabilities rose to $9.54M from $8.60M, and the accumulated deficit grew to $105.67M.

• · Series C preferred stock was fully converted to common shares during H1 2026, eliminating the $41.17M mezzanine equity balance.
• · Derivative liability of $1.89M was newly recognized in H1 2026, while warrant liability decreased from $1.15M to $13,243.
• · Professional fees surged to $4.36M in H1 2026 from $0.82M in H1 2025, a 433% increase.
• · Interest expense increased to $0.99M in H1 2026 from $0.71M in H1 2025.
• · The company had no revenue; all losses are from operating expenses and financing costs.
• · Stockholders' deficit improved from ($48.95M) to ($6.13M) primarily due to the conversion of Series C preferred shares into common equity.

14-08-2026

NexPoint Capital, Inc. reported a net increase in net assets of $2.5M for Q2 2026, reversing a $2.3M net decrease in Q2 2025, driven by a strong recovery in unrealized gains ($2.5M vs. -$2.6M). However, net investment income dropped sharply to $49,645 from $215,814 in the prior-year quarter, and total investment income fell 35.5% to $353,978. Net asset value per share improved to $4.55 from $4.39 at year-end 2025, but remains below the $5.33 level at mid-2025.

• · Share repurchases totaled $734,215 in H1 2026, down from $1,556,648 in H1 2025.
• · Cash and cash equivalents increased to $616,357 from $352,412 at year-end 2025.
• · Distributions to stockholders in H1 2026 were $1,046,322 (cash), compared to $1,069,996 in H1 2025.
• · Weighted average shares outstanding declined to 8,364,018 in Q2 2026 from 8,611,318 in Q2 2025.
• · PIK interest income in Q2 2026 was $48,569 vs $43,045 in Q2 2025, a modest increase of 12.8%.
• · Dividend income from affiliated investments decreased in Q2 2026 ($185,241) vs Q2 2025 ($238,176), down 22.2%.
• · Net realized loss on investments was $46,694 in Q2 2026, compared to a gain of $103,535 in Q2 2025.
• · Deferred tax liability increased to $139,177 from $106,932 at year-end 2025.
• · Adviser expense waivers/recoupments totaled $76,335 in Q2 2026 vs $145,163 in Q2 2025.
• · The portfolio's largest sector concentrations are Preferred Stocks (31.3% of investments) and Common Stocks (42.7%).

14-08-2026

Atlassian Corp reported total revenues of $6,572,308,000 for fiscal year 2026, a 26% increase from $5,215,304,000 in FY2025, driven by strong subscription growth of 27% to $6,262,194,000. The company achieved a positive operating income of $10,355,000 compared to an operating loss of $130,392,000 in the prior year, and reduced its net loss to $53,828,000 from $256,687,000. However, free cash flow declined 6.8% to $1,319,075,000, marketing and sales expenses surged 36% to $1,541,178,000, and interest income fell 38% to $69,710,000.

• · Restructuring charges totaled $285,370,000, including $203,917,000 in severance and termination benefits, $1,432,000 in stock-based compensation, and $80,021,000 in lease consolidation costs.
• · Marketing and sales expenses grew 36% YoY to $1,541,178,000, significantly outpacing revenue growth of 26%.
• · Interest income declined 38% to $69,710,000, while interest expense increased 62% to $49,450,000.
• · Provision for income taxes decreased 52% to $75,878,000.
• · Net cash provided by operating activities decreased 7.3% to $1,353,135,000 from $1,460,393,000.
• · Capital expenditures decreased to $34,060,000 from $44,850,000.

14-08-2026

Avnet Inc. reported strong fiscal 2026 results with sales of $27,633M, up 24.5% YoY from $22,201M, driven by broad-based growth across all segments and regions. Operating income surged 40.9% to $725M and net income rose 39.2% to $334M. However, gross profit margin contracted 31 bps to 10.4%, and the effective tax rate spiked to 28.5% from 4.1% in the prior year, tempering bottom-line gains.

• · Semiconductors segment sales grew 26.2% YoY to $21,711.0M from $17,207.9M.
• · IP&E segment sales grew 15.8% YoY to $4,605.2M from $3,976.9M.
• · Computers segment sales grew 13.7% YoY to $601.6M from $528.9M.
• · Other segment sales grew 46.8% YoY to $714.9M from $487.1M.
• · Asia region contributed 48.5% of total sales in FY2026, up from 47.2% in FY2025.
• · Restructuring, integration, and other expenses increased 24.4% YoY to $135M.
• · Interest and other financing expenses, net increased slightly by 1.8% to $251M.
• · Total assets increased 27.3% to $15,425.4M from $12,118.6M.
• · Short-term debt surged to $733.9M from $87.3M, a 741% increase.
• · Accounts payable increased 73.6% to $6,054.3M from $3,487.4M.
• · Goodwill decreased 3.2% to $810.2M from $837.0M.
• · Accumulated other comprehensive loss widened to $(375.4)M from $(257.7)M.
• · The company had $3,233.4M in long-term debt obligations, with $733.9M due within one year.

14-08-2026

DSwiss Inc (DQWS) filed its 10-Q for the quarter ended June 30, 2026, reporting a net loss of $2,502 for Q2 2026 versus net income of $32,128 in Q2 2025, a significant decline. Revenue dropped sharply to $511,781 from $1,021,340 in the prior-year quarter, a 49.9% decrease. However, the company reduced its accumulated deficit slightly and improved its stockholders' equity from negative $9,346 to negative $7,820.

• · Cost of revenue decreased to $342,427 in Q2 2026 from $872,732 in Q2 2025, a 60.8% decline.
• · Selling, general and administrative expenses increased to $168,075 in Q2 2026 from $135,499 in Q2 2025, a 24.0% increase.
• · Cash used in operating activities was $5,298 in H1 2026 vs cash generated of $148,585 in H1 2025.
• · Total liabilities decreased to $645,043 as of June 30, 2026 from $686,482 as of December 31, 2025.
• · Accumulated deficit improved slightly to ($1,463,001) from ($1,464,790).
• · Revenue from a related party was $107,336 in Q2 2026 vs $6,892 in Q2 2025, a significant increase.

14-08-2026

Irenic Acquisition Corp. filed its Form 10-Q for the quarter ended June 30, 2026, reporting net income of $1.37M for the three-month period and $1.31M since inception (March 4, 2026). The company, a SPAC, completed its IPO during the period, raising $247.5M in net proceeds from unit sales and placing $254.1M in a trust account. However, the company reported a loss from operations of $171,066 for the quarter and an accumulated deficit of $8.95M as of June 30, 2026, reflecting the early-stage costs of a blank-check company.

• · The company was incorporated on March 4, 2026, and this is its first quarterly report as a public entity.
• · The company's operating loss of $171,066 for the quarter was offset by $1.53M in interest income from the trust account, resulting in net income.
• · Total shareholders' deficit of $8.95M reflects the accretion of Class A shares to their redemption value of $10.06 per share.
• · The company has 25,253,188 Class A shares subject to possible redemption, representing the vast majority of its public float.
• · Deferred underwriting fees of $10.1M are payable upon completion of a business combination.

14-08-2026

NewHold Investment Corp IV, a blank check company, reported net income of $854,000 for Q2 2026 and $816,000 for the first half of 2026, driven by interest income on trust investments. The company completed its IPO in June 2026, raising $201.25 million, and holds $202.7 million in trust. However, it has an accumulated deficit of $5.59 million and negative working capital, reflecting typical SPAC startup costs.

• · IPO completed in June 2026, raising $201.25 million from sale of Units and $6.413 million from Private Placement Units.
• · Trust account balance of $202.715 million as of June 30, 2026.
• · Deferred underwriting payable of $7.044 million.
• · Accumulated deficit of $5.59 million as of June 30, 2026.
• · Class A ordinary shares subject to possible redemption: 20,125,000 shares at redemption value of $10.06 per share.
• · Net cash used in operating activities for H1 2026: $531,000.
• · Net cash provided by financing activities for H1 2026: $203.111 million.
• · Company is a shell company and an emerging growth company.
• · Warrants exercisable at $11.50 per share.

14-08-2026

Lakewood-Amedex Biotherapeutics reported no revenue for Q2 2026 and H1 2026, with net losses widening significantly to $3.77M (Q2) and $4.70M (H1) from $0.66M and $1.20M in the prior-year periods. Operating expenses surged, particularly general and administrative costs, while the company raised $6.8M in net proceeds from a Series C preferred stock issuance and converted all Series A and B preferred stock into common stock, improving its cash position to $2.58M as of June 30, 2026.

• · No revenue generated in Q2 2026 or H1 2026.
• · Total operating expenses increased to $3.79M in Q2 2026 from $0.64M in Q2 2025, and to $4.68M in H1 2026 from $1.18M in H1 2025.
• · Net cash used in operating activities was $2.45M in H1 2026, up from $0.91M in H1 2025.
• · The company issued 2,434,080 shares of common stock for professional services during H1 2026.
• · All Series A and Series B preferred stock were converted into common stock during Q2 2026.
• · Series B preferred stock accumulated dividends of $10.59M were accrued and converted into common stock during Q2 2026.
• · As of June 30, 2026, the company had 157,064 potentially dilutive shares (warrants and options).

14-08-2026

Apollo Asset Backed Credit Co LLC reported strong growth for the six months ended June 30, 2026, with total investment income surging 262% to $66.2M and net investment income increasing 308% to $46.8M compared to the same period in 2025. Total net assets grew 20% to $1.94B from $1.61B at year-end 2025, driven by Series II expansion. However, the company recorded a net realized and unrealized loss of $19.1M for the six-month period, compared to a gain of $8.1M in the prior year, and cash flow from operations was negative $204M, reflecting significant investment activity.

• · Series II net assets grew 25% to $1.63B, while Series I net assets remained nearly flat at $312.3M.
• · Net cash used in operating activities was $204M for the six months ended June 30, 2026, compared to $564.7M used in the prior year period.
• · Proceeds from issuance of shares totaled $404.1M for the six months, while share repurchases were $71.7M.
• · Level III investments, which are valued using significant unobservable inputs, totaled $1.48B as of June 30, 2026, representing 76% of total investments.
• · The company had $146.5M in repurchase agreements outstanding as of June 30, 2026, down from $171.4M at year-end 2025.
• · Performance fees payable dropped to zero as of June 30, 2026, from $5.8M at December 31, 2025.
• · Interest income for the six months ended June 30, 2026 was $53.3M, up from $13.8M in the prior year period.
• · Dividend income for the six months ended June 30, 2026 was $12.9M, up from $4.5M in the prior year period.
• · Total expenses for the six months ended June 30, 2026 were $16.6M, up from $9.5M in the prior year period.
• · The company had a provision for income taxes of $3.1M for the six months ended June 30, 2026, compared to $0.9M in the prior year period.

14-08-2026

AParadise Acquisition Corp. (APADU) reported its first revenue of $17.7M for Q2 2026 following a business combination, but net loss widened significantly to $61.9M in Q2 2026 from $3.0M in Q2 2025, driven by high operating costs and transaction expenses. The company completed a reverse recapitalization, converted SAFEs, and raised $25M in private placement, improving stockholders' equity to $3.1M from a deficit of $1.0M. However, cash decreased to $19.6M from $25.3M at year-end 2025, and accumulated deficit grew to $110.4M.

• · Operating expenses for Q2 2026 were $79.6M, including $52.0M in games, athletes and event operating costs, $16.6M in SG&A, and $10.9M in transaction expenses.
• · Net cash used in operating activities for six months ended June 30, 2026 was $44.0M, compared to $7.5M in the prior year period.
• · The company issued 258,837,933 shares of Class B common stock during the quarter.
• · Accounts payable and accrued expenses increased to $40.1M from $3.0M at year-end 2025.
• · Contract assets of $15.5M were recognized as of June 30, 2026, with no comparable balance at year-end 2025.

14-08-2026

Apollo Infrastructure Co LLC reported a net increase in net assets resulting from operations of $78.455M for the six months ended June 30, 2026, up 136% from $33.215M in the prior-year period, driven by strong unrealized appreciation on investments. However, net investment income turned negative to ($377K) for Q2 2026 versus $10.830M in Q2 2025, and the company recorded a net investment loss of ($1.633M) for Series I in Q2 2026. Total net assets grew 15.7% to $2.009B from $1.736B at year-end 2025, supported by $248.495M in share issuance proceeds and $255M in credit facility borrowings, while cash and cash equivalents declined 13% to $171.459M.

• · Net investment income for Q2 2026 was negative ($377K) compared to positive $10.830M in Q2 2025, driven by a $8.526M provision for income taxes and $2.284M in interest expense on the new credit facility.
• · Series I net investment income was negative ($1.633M) in Q2 2026, while Series II posted positive $1.256M.
• · The company drew $255M on its credit facility during H1 2026, which had no balance at year-end 2025.
• · Net unrealized appreciation on investments was $65.830M in H1 2026, up from $4.751M in H1 2025.
• · Share repurchases totaled $29.705M in H1 2026, up from $9.075M in H1 2025.
• · Net cash used in operating activities was $464.651M in H1 2026, compared to $267.964M in H1 2025.
• · As of June 30, 2026, 64.1% of total investments ($1.347B out of $2.102B) were classified as Level III fair value measurements.

14-08-2026

Cyber Enviro-Tech, Inc. (CETI) reported no revenue for the three and six months ended June 30, 2026 and 2025, with a net loss attributable to common stockholders of $728,185 for Q2 2026 (vs. $970,732 in Q2 2025) and $2,789,925 for H1 2026 (vs. $2,114,283 in H1 2025). While operating expenses decreased significantly (Q2: -55% YoY; H1: -54% YoY), the company's cash position fell sharply from $50,230 at year-end 2025 to just $6,796 at June 30, 2026, and total liabilities rose to $7.5M against total assets of $3.4M, resulting in a stockholders' deficit of $4.1M. The company continues to rely on debt and equity financing, with convertible notes payable (net of discount) increasing from $1.2M to $2.8M and a derivative liability of $2.7M.

• · No revenue generated in any period reported (Q2 2026, Q2 2025, H1 2026, H1 2025).
• · Operating cash flow used was $701,828 in H1 2026 vs. $1,769,857 in H1 2025, a 60% improvement.
• · Net cash from financing activities was $658,394 in H1 2026, down 72% from $2,352,676 in H1 2025.
• · The company issued 29,047,900 common shares for cash proceeds of $137,192 in H1 2026.
• · A total of 1,940,417 Series D Convertible Preferred shares were issued in exchange for common shares during H1 2026.
• · Shares issued for conversion of convertible notes payable totaled 10,500,000 common shares in H1 2026.
• · Derivative liability is classified as Level 3 (unobservable inputs) and totaled $2,655,735 at June 30, 2026.
• · Interest expense increased 95% to $974,521 in H1 2026 from $499,724 in H1 2025.
• · Loss on issuance of derivatives surged to $1,246,006 in H1 2026 from $75,214 in H1 2025.
• · The company had a loss on extinguishment of debt of $379,644 in H1 2026 (none in H1 2025).

14-08-2026

Cartesian Growth Corp II (REEUF) reported a net loss of $699,615 for Q2 2026, compared to a net loss of $152,231 in Q2 2025, driven by a $497,000 loss from the change in fair value of warrant liabilities and higher general and administrative costs ($527,434 vs. $262,245). For the six months ended June 30, 2026, the company posted net income of $2,395,143, up from $407,633 in the prior-year period, primarily due to a $2,650,667 gain from the change in fair value of warrant liabilities. Cash decreased to $149,017 from $162,853 at year-end 2025, and the company continues to operate with a shareholders' deficit of $24,413,841.

• · The company had no operating revenue; all income/loss derived from changes in fair value of liabilities and interest on trust account.
• · Warrant liabilities decreased from $4,473,000 at Dec 31, 2025 to $1,822,333 at June 30, 2026, a 59.3% decline.
• · Convertible promissory notes – related party increased slightly from $5,000,796 to $5,202,610.
• · Net cash used in operating activities was $263,836 for H1 2026, compared to $257,068 in H1 2025.
• · The company received $250,000 from a convertible promissory note in H1 2026, same as in H1 2025.
• · Basic and diluted net loss per share for Q2 2026 was $(0.08) for both redeemable and non-redeemable shares, versus $(0.01) in Q2 2025.
• · Basic and diluted net income per share for H1 2026 was $0.27 for both classes, versus $0.03 in H1 2025.

14-08-2026

DISCIPLINED GROWTH ACQUISITION Corp filed its Form 10-Q for the quarterly period ended June 30, 2026, reporting net income of $347,039 for the three months and $265,493 since inception (January 19, 2026). The company completed its IPO and private placement, raising $157.5M from the unit offering and $3.55M from private placement units, with $158.8M held in trust. However, the company reported a loss from operations of $259,896 for the quarter and $341,442 since inception, reflecting early-stage operating costs with no business combination yet completed.

• · The company was incorporated on January 19, 2026, and has not yet completed a business combination.
• · Total operating expenses for the three months ended June 30, 2026 were $259,896, consisting of $223,856 in general and administrative costs and $36,040 in formation costs.
• · Interest income on the Trust Account was $537,468 for both the three-month and inception-to-date periods.
• · The over-allotment option liability had a fair value of $195,791 at June 30, 2026, with a change in fair value of $69,467 recognized as income.
• · Net cash used in operating activities was $292,778 from inception through June 30, 2026.
• · Net cash provided by financing activities was $159,276,567, primarily from IPO and private placement proceeds.
• · The company had no revenue and no business operations other than those related to its formation and IPO.

14-08-2026

D. Boral Acquisition I Corp. (DBCA) filed its Form 10-Q for the quarterly period ended June 30, 2026, reporting a net income of $2.47M for Q2 2026 and $3.71M for the first half of 2026, compared to zero net income in the prior-year period (inception through June 30, 2025). The company completed its IPO during the period, raising $287.5M in gross proceeds from the issuance of 28,750,000 Class A ordinary shares and $2.0M from a private placement, resulting in total assets of $292.1M as of June 30, 2026, up from $0.19M at year-end 2025. However, operating cash flow was negative at ($0.56M) for the six-month period, reflecting ongoing formation and operating expenses of $0.31M.

• · The company's operating cash flow was negative ($0.56M) for the six months ended June 30, 2026, driven by interest income earned on trust account ($4.02M) and changes in prepaid expenses ($0.31M).
• · Total formation and operating expenses for the six months ended June 30, 2026 were $0.31M, compared to $0 in the prior-year period.
• · The company had 28,750,000 Class A ordinary shares subject to possible redemption at a redemption value of $10.14 per share as of June 30, 2026.
• · The warrants have a redemption trigger if the Class A ordinary shares trade at or above $18.00 per share for 10 trading days within a 20-trading-day period ending three trading days before the redemption notice.

14-08-2026

Standex International's fiscal 2026 10-K reports net sales of $891.6 million, up 12.8% from $790.1 million in fiscal 2025, driven by acquisitions and organic growth, though partially offset by divestitures. Income from operations surged to $193.6 million from $93.5 million, boosted by a $57.1 million gain on sale of business. The company completed the acquisition of the remaining 9.9% of Narayan Powertech and divested Federal Industries for $68.3 million, simplifying its portfolio. However, net debt remains significant at $339.2 million, and the company faces headwinds in general automotive markets.

• · CEO David A. Dunbar adopted a Rule 10b5-1 trading plan on May 21, 2026, to sell up to 13,000 shares, with sales commencing on or after August 31, 2026, and ending by August 31, 2027.
• · The company acquired the remaining 9.9% interest in Narayan Powertech on July 2, 2026, making it a wholly-owned subsidiary.
• · Divestiture of Federal Industries for $68.3 million cash proceeds completed on March 9, 2026.
• · Restructuring costs increased to $12.2 million in FY2026 from $6.9 million in FY2025.
• · Deal-related expenses decreased to $4.1 million in FY2026 from $21.4 million in FY2025.
• · Organic sales change was positive $43.6 million in FY2026, compared to negative $53.8 million in FY2025.
• · Effect of acquisitions on sales was $66.4 million in FY2026, down from $123.6 million in FY2025.
• · Effect of business divestitures reduced sales by $12.8 million in FY2026.
• · Redeemable noncontrolling interest purchase obligation of $64.0 million recorded as of June 30, 2026.
• · Total assets increased to $1,585.7 million from $1,566.9 million.
• · The company expects continued growth in electrical grid and defense markets, but softness in general automotive end markets.

14-08-2026

Oxley Bridge Acquisition Ltd filed its 10-Q for the quarter ended June 30, 2026, reporting net income of $2.16M for Q2 2026 and $4.28M for the first half of 2026, compared to net income of $0.02M and $0.009M in the same periods of 2025. The improvement was driven by a sharp increase in income on investments held in the Trust Account ($2.31M in Q2 2026 vs $0.12M in Q2 2025). However, operating losses widened to $0.15M in Q2 2026 from $0.09M in Q2 2025, and cash used in operations increased to $0.25M for the six months ended June 30, 2026 from $0.09M in the prior year period. Cash equivalents declined to $0.73M from $0.98M at year-end 2025.

• · The company had no revenue-generating operations; all income came from trust account investments.
• · General and administrative expenses increased to $112,614 in Q2 2026 from $91,286 in Q2 2025.
• · Administrative expenses – related party were $37,500 in Q2 2026 vs $2,083 in Q2 2025.
• · Dividend income of $6,421 was recognized in Q2 2026 (none in Q2 2025).
• · The company had a deferred underwriting fee liability of $12,045,000 unchanged from year-end 2025.
• · Class A ordinary shares subject to possible redemption were remeasured to redemption value, increasing the redemption amount by $2.31M in Q2 2026.
• · No financing or investing cash flows occurred in the six months ended June 30, 2026, as the IPO was completed in 2025.
• · The company had a working capital deficit of $0.69M as of June 30, 2026 (current assets $0.85M minus current liabilities $0.16M).
• · Shareholders' deficit increased to $11.35M from $11.06M at year-end 2025.

14-08-2026

Scientific Industries Inc. reported a net loss of $1.23M for Q2 2026 (ending June 30, 2026), an improvement from the $1.52M loss in Q2 2025, driven by a 36% revenue increase to $1.47M. However, operating expenses remained high at $1.90M, and the company's cash position declined sharply from $955K to $616.5K, while total assets fell from $12.6M to $10.1M. The accumulated deficit widened to $37.97M, and the company continues to report losses from continuing operations with no income tax expense.

• · Operating expenses decreased 13.7% in Q2 2026 ($1.90M) vs Q2 2025 ($2.20M), driven by lower G&A and selling expenses.
• · Research and development expenses increased slightly to $694.5K in Q2 2026 from $677.1K in Q2 2025.
• · Total inventories increased to $1.94M as of June 30, 2026 from $1.75M as of December 31, 2025.
• · Net cash used in operating activities improved to $1.90M for H1 2026 from $3.20M for H1 2025.
• · The company had no income from discontinued operations in 2026, compared to $273.1K in Q2 2025 and $552.7K in H1 2025.
• · Level 3 assets increased slightly to $515K as of June 30, 2026 from $506.4K as of December 31, 2025.
• · The company's accumulated other comprehensive income decreased to $133.6K from $178K due to foreign currency translation losses.

14-08-2026

Kingfish Holding Corp reported a net loss of $47,083 for Q3 FY2026 (three months ended June 30, 2026), compared to net income of $48,824 in the same quarter last year, a swing of approximately $95,907. For the nine-month period, net loss was $237,312 versus net income of $579,843 in the prior year. Revenue declined 26.8% to $757,456 in Q3 and 43.6% to $2,264,736 for the nine months, while operating expenses increased 7.9% in Q3, driving the company from profitability to a loss. Cash and cash equivalents fell 62.8% to $383,300 from $1,030,185 at September 30, 2025.

• · Cost of goods sold decreased 27.9% in Q3 to $415,273 from $575,769, but gross profit margin fell to 45.2% from 44.3%.
• · Professional fees increased 42.0% in Q3 to $71,460 from $50,309.
• · Director compensation of $18,920 in Q3 FY2026 was a new expense (nil in prior year).
• · Interest expense increased 18.8% in Q3 to $21,012 from $17,684.
• · Cash used in operating activities was $364,929 for 9M FY2026 vs. cash provided of $647,582 in prior year.
• · Capital expenditures of $361,956 for property and equipment in 9M FY2026 (nil in prior year).
• · Right-of-use asset increased to $312,680 from $197,369, with a new office lease obligation of $1,353,215.
• · Accrued interest payable rose to $316,716 from $257,371, a 23.1% increase.
• · Taxes payable decreased 43.4% to $118,763 from $209,981.
• · Basic and diluted EPS was ($0.06) in Q3 FY2026 vs. $0.06 in Q3 FY2025.

14-08-2026

Lifeloc Technologies reported a net loss of $134,330 for Q2 2026, a significant improvement from a net loss of $393,639 in Q2 2025, driven by higher product sales and lower operating expenses. However, the company remains unprofitable on both a quarterly and six-month basis, with an accumulated deficit of $2.12 million as of June 30, 2026. While revenue grew 10.2% year-over-year in Q2, royalty and rental income declined, and operating cash flow remained negative at -$262,577 for the first half of 2026.

• · Operating cash flow was negative $262,577 in H1 2026, improved from negative $389,576 in H1 2025.
• · The company received $500,000 in proceeds from a related party term loan during H1 2026, which helped boost cash.
• · Inventories increased to $2,839,516 as of June 30, 2026 from $2,633,614 at year-end 2025, a 7.8% rise.
• · Accounts payable nearly doubled to $501,118 from $301,627 at year-end 2025.
• · Total liabilities increased to $3,262,172 from $2,582,790 at December 31, 2025, a 26.3% increase.
• · Stockholders' equity decreased to $3,816,735 from $4,103,778 at year-end 2025, a 7.0% decline.
• · Depreciation and amortization expense fell to $135,962 in H1 2026 from $216,419 in H1 2025, a 37.2% decrease.

14-08-2026

Nektar Therapeutics reported a net loss of $40.6M for Q2 2026, slightly improved from a $41.6M loss in Q2 2025, while total revenue declined 9.3% YoY to $10.1M. The company significantly strengthened its balance sheet through a $783.7M underwritten offering and a $106.7M at-the-market offering, boosting total cash and investments to $1.02B as of June 30, 2026, compared to $245.8M at year-end 2025. However, operating expenses rose 10.7% YoY in Q2, driven by a 31% increase in R&D spending, and cash used in operations widened to $120.1M for the first half of 2026 versus $94.8M in the prior-year period.

• · Non-cash royalty revenue (the only revenue source) declined 9.3% YoY in Q2 2026 to $10.1M.
• · R&D expense increased 31% YoY in Q2 2026 to $39.1M, while G&A expense decreased 25.2% to $12.8M.
• · Restructuring and impairment charges were $0.6M in Q2 2026, up from $0.4M in Q2 2025.
• · Non-cash interest expense on liabilities related to sales of future royalties rose to $7.2M in Q2 2026 from $5.4M in Q2 2025.
• · Interest income surged to $9.3M in Q2 2026 from $2.0M in Q2 2025, reflecting the larger investment portfolio.
• · Loss from equity method investment narrowed to $0.3M in Q2 2026 from $2.4M in Q2 2025.
• · Cash used in operations for H1 2026 was $120.1M, up 26.7% from $94.8M in H1 2025.
• · The company raised $783.7M net from an underwritten offering and $106.7M net from an at-the-market offering during H1 2026.
• · Total stockholders' equity surged to $903.1M at June 30, 2026 from $89.8M at December 31, 2025, primarily due to the equity offerings.
• · Accumulated deficit widened to $3.85B at June 30, 2026 from $3.76B at December 31, 2025.

14-08-2026

Texas Ventures Acquisition III Corp (TVACW) reported net income of $1.35M for Q2 2026 and $0.88M for H1 2026, down from $2.94M and $2.90M in the prior-year periods. The decline was driven by the absence of a $1.44M non-recurring gain from the change in fair value of warrant liability in 2025, while general and administrative expenses surged to $3.24M in H1 2026 from $0.28M a year earlier. Cash dropped to $0.26M from $0.86M at year-end 2025, and the company continues to operate with a shareholders' deficit of $11.48M.

• · Net cash used in operating activities was $599,234 in H1 2026 vs $324,230 in H1 2025.
• · Accrued expenses ballooned to $2,744,164 at June 30, 2026 from $231,427 at year-end 2025.
• · Deferred underwriting commissions remained unchanged at $9,000,000.
• · The company had no financing or investing cash flows in H1 2026.
• · Shareholders' deficit worsened to $11,480,484 from $8,241,887 at year-end 2025.
• · Basic and diluted net income per share for both Class A and Class B was $0.03 for H1 2026 vs $0.20 for H1 2025.

14-08-2026

Acro Biomedical reported no revenue for the three and six months ended June 30, 2026, and continues to operate at a net loss. The net loss widened to $65,130 for the first half of 2026 from $25,863 in the prior-year period, driven by a sharp increase in general and administrative expenses. However, cash used in operations improved significantly to $60,325 from $116,515, and the company ended the period with $3,648 in cash versus only $26 a year ago, though total assets fell sharply from $14,098 to $3,648.

• · The company had zero revenue for both the three-month and six-month periods ended June 30, 2026 and 2025.
• · General and administrative expenses surged to $77,825 for the first half of 2026 from $22,548 in the same period of 2025, a 245% increase.
• · Liability forgiveness of $20,000 was recognized in the six months ended June 30, 2026, with no comparable item in 2025.
• · Due to related parties increased to $385,387 at June 30, 2026 from $325,512 at December 31, 2025.
• · The company's working capital deficit worsened to $444,789 from $386,964 at year-end 2025.
• · Cash used in operations improved to $60,325 from $116,515, but the company remains dependent on related-party financing.
• · No cash was paid for income taxes or interest in either period.

14-08-2026

Bain Capital Private Credit reported strong growth for the six months ended June 30, 2026, with total investment income more than doubling to $108.2M (up 108.5% YoY) and net investment income rising to $53.3M (up 111.4% YoY). Total assets grew 39.2% to $2.43B, driven by a significant increase in investments at fair value. However, the company recorded a net loss on investments of $8.8M for the six-month period, compared to a net gain of $1.8M in the prior year, and net asset value per share declined slightly from $25.98 to $25.89.

• · Net realized and unrealized losses totaled $8.8M for H1 2026, compared to net gains of $1.8M in H1 2025, driven primarily by a $10.1M net change in unrealized depreciation on non-controlled/non-affiliate investments.
• · Interest and debt financing expenses nearly doubled to $33.6M in H1 2026 from $15.6M in H1 2025, reflecting increased borrowings.
• · The company had $1.24B in debt (net) as of June 30, 2026, up 56.8% from $790.3M at year-end 2025.
• · Cash used in operating activities was $578.5M for H1 2026, compared to $446.1M in H1 2025, driven by $1.20B in investment purchases.
• · Proceeds from issuance of Common Shares totaled $232.2M in H1 2026, while share repurchases were $11.9M.
• · The company had $4.21M in unrealized depreciation on interest rate swaps as of June 30, 2026, compared to $447K in unrealized appreciation at year-end 2025.
• · High Tech Industries portfolio represented 28.0% of net assets, with a total market value of $318.0M.
• · The company's largest single investment in the High Tech sector was G-3 Frax Acquisition LLC at $34.1M market value.

14-08-2026

Range Capital Acquisition Corp II (a SPAC) reported net income of $1.93M for Q2 2026 and $3.78M for H1 2026, driven by interest earned on trust account securities. However, operating losses widened to $158,970 (Q2) and $382,512 (H1) as general and administrative costs increased, and cash declined 27% from $1.12M to $0.82M during H1 2026. The company has not yet announced a business combination target.

• · Net cash used in operating activities was $321,163 for H1 2026, compared to $15,720 for the prior period (inception through June 30, 2025).
• · The company had $8,050,000 in deferred underwriting fees as of both June 30, 2026 and December 31, 2025.
• · Total shareholders' deficit worsened to ($7,242,258) as of June 30, 2026 from ($6,875,020) as of December 31, 2025.
• · The company had no revenue from operations; all income came from interest on trust securities and bank investments.
• · No business combination has been announced as of the filing date.

14-08-2026

NextPlat Corp reported a net loss of $144,000 for Q2 2026, a significant improvement from a $1.789M loss in Q2 2025, driven by a 62.8% increase in gross profit to $4.694M. However, total revenues declined 10.3% year-over-year to $11.881M, with Healthcare Operations revenue falling 14.4% to $7.803M, partially offset by a 136.4% surge in pharmacy contract revenue. The company's cash position decreased to $11.940M from $13.709M at year-end 2025, and operating cash flow improved to negative $1.498M from negative $3.100M in the prior-year period.

• · Total liabilities increased to $12.187M as of June 30, 2026 from $10.043M at December 31, 2025.
• · Accounts payable and accrued expenses rose to $10.252M from $8.265M.
• · Operating right-of-use assets increased to $572,000 from $189,000, reflecting a lease modification.
• · Stock-based compensation was $322,000 for H1 2026 versus $11,000 in H1 2025.
• · The company had an accumulated deficit of $61.325M as of June 30, 2026.
• · Basic and diluted loss per share improved to $(0.05) for Q2 2026 from $(0.69) for Q2 2025.
• · No investing activities occurred in H1 2026, compared to $98,000 provided in H1 2025.

14-08-2026

McKinley Acquisition Corp (MKLYU) reported net income of $899,136 for Q2 2026 and $2,185,631 for H1 2026, compared to net losses of $54,820 and $63,421 in the prior-year periods, driven by interest income on the trust account. However, operating expenses surged to $628,953 in Q2 2026 from $54,820 in Q2 2025, and cash used in operations increased to $635,454 in H1 2026 from $111,509 in the prior period. The company's accumulated deficit widened to $3,841,152 as of June 30, 2026, from $2,303,752 at year-end 2025.

• · Deferred underwriting commissions increased to $5,175,000 as of June 30, 2026 from $4,500,000 at December 31, 2025 due to exercise of over-allotment option.
• · Remeasurement of Class A ordinary shares to redemption value totaled $3,048,031 for H1 2026.
• · Subscription note receivable of $500,000 remained unchanged from December 31, 2025.
• · No proceeds from financing activities in H1 2026, compared to $111,509 in the prior period.

14-08-2026

Intapp, Inc. reported total revenues of $577.8M for FY2026, up 15% YoY from $504.1M, driven by SaaS revenue growth of 27% to $422.8M. However, license revenue declined 14% to $103.4M and professional services revenue fell 1% to $51.6M. The company's net loss widened to $41.3M from $18.2M in the prior year, primarily due to a 19% increase in operating expenses and a 96% rise in income tax expense. Cash and cash equivalents decreased sharply to $162.8M from $313.1M, largely due to financing activities.

• · Professional services gross profit remained negative at -$8.1M in FY2026, worsening from -$6.0M in FY2025.
• · Total stock-based compensation expense rose 36% YoY to $120.0M, representing 21% of total revenues.
• · Deferred revenue (current) increased to $315.1M from $257.0M, indicating strong future SaaS revenue visibility.
• · The company's accumulated deficit grew to $823.6M from $505.4M.
• · Net cash used in financing activities was $282.7M in FY2026, compared to $41.2M provided in FY2025, likely reflecting share repurchases or debt repayments.
• · Goodwill remained nearly flat at $326.1M, while intangible assets declined to $29.0M from $40.7M due to amortization.

14-08-2026

BurTech Acquisition Corp II filed its Form 10-Q for the quarter ended June 30, 2026, reporting net income of $168,096 for the three months and $153,008 for the six months. The company completed its IPO during the period, raising $79.2 million in net proceeds and placing $80.4 million into its trust account. However, the company reported a loss from operations of $168,262 for the three months and $183,350 for the six months, and net cash used in operating activities was $283,892 for the six-month period.

• · Net cash used in operating activities for the six months ended June 30, 2026 was $283,892.
• · The company had a loss from operations of $168,262 for the three months and $183,350 for the six months ended June 30, 2026.
• · Interest earned on marketable securities held in Trust Account was $273,358 for both the three and six month periods.
• · The company issued 252,000 Private Placement Units for proceeds of $2,520,000.
• · Founder Shares of 514,286 were forfeited during the period.
• · The redemption value of Class A ordinary shares is $10.08 per share, triggered if the stock price equals or exceeds $18.00 per share for 20 trading days within a 30-trading day period.

14-08-2026

zSpace reported Q2 2026 revenue of $5.4M, down 27.7% YoY from $7.5M, and a net income of $0.3M versus a net loss of $6.1M in Q2 2025, driven by a $4.1M gain on debt extinguishment and a $1.2M vendor settlement gain. However, operating loss improved to $2.5M from $6.3M, but cash decreased to $0.9M from $1.0M at year-end 2025, and the company continues to face going concern risks with a stockholders' deficit of $13.2M.

• · Q2 2026 gross profit was $3.0M, down from $3.2M in Q2 2025, with gross margin improving to 56.4% from 42.6%.
• · Operating expenses decreased 41.3% YoY in Q2 2026 to $5.6M, driven by lower R&D, selling and marketing, and G&A, plus a $1.2M vendor settlement gain.
• · The company issued 30.2 million shares for debt restructuring in Q2 2026, increasing share count from 1.6 million to 37.1 million.
• · Convertible debt decreased from $6.2M to $0.8M (current) and noncurrent increased from $2.7M to $5.0M, reflecting restructuring.
• · Net cash used in operating activities improved to $5.0M in H1 2026 from $11.6M in H1 2025.
• · The company raised $3.0M from Series P Preferred Stock issuance and $4.0M from convertible debt in H1 2026.
• · Accumulated deficit increased to $322.1M as of June 30, 2026 from $315.8M at year-end 2025.

14-08-2026

CaliberCos Inc. reported a net loss attributable to the company of $3,358 thousand for Q2 2026, an improvement from a $5,299 thousand loss in Q2 2025, and a six-month loss of $6,977 thousand versus $9,706 thousand in the prior year. Total revenues declined 17% YoY in Q2 to $4,194 thousand, driven by the absence of hospitality revenues and lower asset management fees, while operating costs rose 24% YoY. The company also recorded a $324 thousand loss from changes in fair value of digital assets in Q2 and a $2,220 thousand loss for the six months, and total assets increased to $177,659 thousand from $135,396 thousand at year-end 2025.

• · Asset management revenues declined 14.4% YoY in Q2 2026 to $3,205 thousand from $3,746 thousand, and were roughly flat for H1 2026 at $6,869 thousand versus $6,942 thousand.
• · Consolidated funds – hospitality revenues were $0 in Q2 and H1 2026, compared to $1,138 thousand and $5,057 thousand in the prior-year periods.
• · Consolidated funds – other revenues increased significantly to $1,072 thousand in Q2 2026 from $167 thousand in Q2 2025, and to $1,668 thousand for H1 2026 from $312 thousand.
• · Operating costs increased 23.7% YoY in Q2 2026 to $4,541 thousand from $3,671 thousand, while H1 operating costs were roughly flat at $7,629 thousand versus $7,715 thousand.
• · Change in fair value of digital assets resulted in a loss of $324 thousand in Q2 2026 and $2,220 thousand for H1 2026; no such loss was recorded in 2025.
• · Interest expense decreased to $1,313 thousand in Q2 2026 from $1,738 thousand in Q2 2025, and to $2,700 thousand for H1 2026 from $3,349 thousand.
• · The company issued 1,757 thousand shares of Class A common stock in Q1 2026, raising $3,472 thousand net of issuance costs.
• · Series AA preferred stock increased to 359,215 shares issued and outstanding as of June 30, 2026, from 221,434 shares at year-end 2025.
• · Stockholders' equity attributable to CaliberCos Inc. turned negative at ($1,441) thousand as of June 30, 2026, versus $1,333 thousand at December 31, 2025.
• · Cash used in operating activities increased to $5,290 thousand for H1 2026 from $2,908 thousand in H1 2025.

14-08-2026

Inflection Point Acquisition Corp. IV (now Merlin) reported a net loss of $58.4M for Q2 2026, a significant increase from $16.3M in Q2 2025, driven by higher operating expenses and a $26.1M loss from changes in fair value of warrant liabilities. Revenue declined 29% YoY to $2.2M, and gross profit turned negative. The company completed a merger and multiple PIPE financings, raising substantial cash, but continues to face operational losses and a growing accumulated deficit.

• · Gross profit turned negative: -$119 in Q2 2026 vs +$41 in Q2 2025.
• · Operating expenses surged: R&D $16,387 in Q2 2026 vs $6,856 in Q2 2025; G&A $15,576 vs $3,804.
• · Change in fair value of convertible promissory notes: -$87,824 in H1 2026.
• · Series A Preferred Stock deemed dividend on down round: $60,848 in Q2 2026.
• · Net cash used in operating activities: -$50,896 in H1 2026 vs -$25,220 in H1 2025.
• · Financing activities provided $181,493 in H1 2026, primarily from PIPE issuances.
• · Accumulated deficit grew to $699,899 as of June 30, 2026.

14-08-2026

Aldabra 4 Liquidity Opportunity Vehicle, Inc. reported net income of $1,645,634 for the three months ended June 30, 2026 and $2,887,889 for the six months ended June 30, 2026, primarily supported by $1,849,247 and $3,749,962 of interest earned on marketable securities held in the Trust Account. However, the company had accumulated deficit of $(11,897,428), total shareholders’ deficit of $(11,896,678), and deferred underwriting fee payable of $12,789,000 as of June 30, 2026.

• · Basic and diluted net income per Class A ordinary share was $0.04 for the three months ended June 30, 2026 and $0.09 for the six months ended June 30, 2026.
• · Net cash used in operating activities was $(890,260), while net cash used in investing activities was $(300,150,000) and net cash provided by financing activities was $301,907,907 for the six months ended June 30, 2026.
• · The company recorded a net loss from operations of $(203,613) for the three months ended June 30, 2026 and $(862,073) for the six months ended June 30, 2026 before Trust Account interest income.
• · The over-allotment option was exercised in full by the underwriters on January 23, 2026.

14-08-2026

21Shares Ethereum ETF (TETH) reported a net decrease in net assets of $4.1M for Q2 2026 and $12.1M for H1 2026, driven by significant realized and unrealized losses on its ether holdings. While the fund generated $27,730 in staking rewards in Q2 (vs. $0 in Q2 2025), net investment income turned positive to $20,797 from a loss of ($9,583) a year ago. However, total net assets fell sharply to $12.9M from $31.3M at year-end 2025, and NAV per share dropped to $7.88 from $14.83, reflecting the decline in ether prices and redemption activity.

• · The fund had no liabilities at either period end.
• · Total ether holdings decreased from 8,685.3821 to 8,185.4684 during Q2 2026, a net reduction of about 5.8%.
• · Ether redemptions totaled 10,835.1655 ether in Q2 2026, while purchases were 10,335.0903 ether.
• · Staking rewards received in Q2 2026 were 13.3463 ether.
• · The fund's accumulated earnings swung from a surplus of $5.8M at Dec 31, 2025 to a deficit of ($6.4M) at Jun 30, 2026.
• · Sponsor fee was fully waived in Q2 2026 ($9,657 waiver vs. $9,657 expense), compared to no waiver in Q2 2025.
• · Net realized loss on ether sold for redemptions was $3.6M in Q2 2026 and $12.8M in H1 2026.
• · Net change in unrealized depreciation on ether was ($445,355) in Q2 2026, versus an appreciation of $6.5M in Q2 2025.

14-08-2026

Kensington Capital Acquisition Corp. VI reported a net loss of $7.6 million for Q2 2026 and $8.4 million for the first half of 2026, driven primarily by a $9.5 million loss on the change in fair value of derivative liabilities. The company completed its initial public offering (IPO) in June 2026, raising $225.4 million in gross proceeds and placing $230 million in its trust account. However, the company has no operating revenue and expects to incur significant costs related to its search for a business combination.

• · The company completed its IPO in June 2026, issuing 23,000,000 units at $10.00 per unit, generating gross proceeds of $230,000,000 before underwriting discounts and offering expenses.
• · The company has not yet identified a target business for its initial business combination and may be unable to complete one within the required timeframe.
• · The company has a working capital loan of $200,000 from a related party and a deferred legal fee of $648,346.
• · The company has derivative liabilities of $15,986,668 related to Private Placement Warrants.
• · The company's Class A ordinary shares subject to possible redemption are recorded at redemption value of $10.11 per share, totaling $232,582,684.
• · The company's net loss per share for both Class A and Class B was $(0.23) for Q2 2026 and $(0.35) for the six months ended June 30, 2026.

14-08-2026

Yellowstone Midco Holdings II, LLC (YSS) reported a net loss of $39.3M for Q2 2026 (vs. $24.2M loss in Q2 2025) and a net loss of $154.2M for H1 2026 (vs. $36.0M loss in H1 2025). Revenue grew 10.4% YoY to $92.5M in Q2 and 9.9% YoY to $208.9M in H1, driven by government segment growth. However, operating expenses surged, particularly stock-based compensation ($95.6M in H1 2026 vs. $0 in H1 2025) and transaction costs ($11.9M vs. $0.1M), leading to a sharply wider operating loss. The company completed an IPO during the period, converting all common and Class P units into common stock and raising $592.8M in net proceeds.

• · The company completed an IPO during H1 2026, converting all common units (50M) and Class P units (240.96M) into common stock, and raising $592.8M in net proceeds.
• · Stock-based compensation expense was $95.6M in H1 2026 vs. $0 in H1 2025, a significant new expense post-IPO.
• · Transaction costs were $11.9M in H1 2026 vs. $0.1M in H1 2025, driven by acquisitions of Orbion and Solestial.
• · Goodwill increased from $674.3M to $793.5M, reflecting acquisition activity.
• · Cash used in operations was $186.6M in H1 2026 vs. $99.8M in H1 2025, a worsening cash burn.
• · Basic and diluted net loss per share was $(0.31) in Q2 2026 vs. $(0.25) in Q2 2025, and $(1.76) in H1 2026 vs. $(0.38) in H1 2025.
• · Total liabilities decreased from $464.4M to $324.4M, primarily due to the conversion of Class P Units derivative liability ($93.4M) into equity.

14-08-2026

Tailwind 2.0 Acquisition Corp. reported net income of $1,290,205 for Q2 2026 and $2,753,271 for H1 2026, driven by interest earned on trust account investments, despite operating losses of $264,782 and $304,080 respectively. Cash decreased from $1,106,825 to $726,504, and the company's accumulated deficit widened to $6,124,071. The company remains a SPAC with no business operations, holding $176,499,651 in trust as of June 30, 2026.

• · Class A ordinary shares subject to possible redemption: 17,250,000 shares at redemption value of $10.23 per share as of June 30, 2026.
• · Class B ordinary shares: 5,750,000 shares issued and outstanding.
• · Deferred underwriting fee payable: $6,900,000.
• · Net cash used in operating activities for H1 2026: $345,321.
• · Net cash used in financing activities for H1 2026: $35,000.
• · Basic and diluted net income per share for Class A and Class B: $0.05 for Q2 2026 and $0.12 for H1 2026.

14-08-2026

Starco Brands reported a net loss of $1.46M for Q2 2026, improving from a $1.85M loss in Q2 2025, while revenue declined 26% to $7.84M from $10.59M. For the first half of 2026, the company swung to a net loss of $2.29M from a $0.13M profit in H1 2025, with revenue down 18% to $16.82M. Cash and cash equivalents fell 50% to $0.90M from $1.82M at year-end 2025, and the accumulated deficit widened to $104.58M.

• · Operating loss improved to $1.26M in Q2 2026 from $1.36M in Q2 2025, but swung to a loss of $1.84M in H1 2026 from a profit of $1.18M in H1 2025.
• · Marketing, general and administrative expenses decreased 33% to $2.15M in Q2 2026 from $3.19M in Q2 2025.
• · Net cash used in operating activities improved to $0.77M in H1 2026 from $0.86M in H1 2025.
• · Total assets decreased 4.8% to $34.14M from $35.86M at year-end 2025.
• · Non-controlling interest was $9.02M as of June 30, 2026, down slightly from $9.08M at December 31, 2025.
• · The company had no provision for income taxes in any period presented.

14-08-2026

LaFayette Acquisition Corp. (LAFAU) reported net income of $890,986 for Q2 2026 and $1,730,914 for H1 2026, compared to a net loss of $10,421 in the prior-year periods, driven by interest earned on trust account marketable securities ($1,034,576 in Q2, $2,057,164 in H1). However, operating losses widened to $143,590 (Q2) and $326,250 (H1) from $10,421 in the prior-year periods, and cash declined 34.8% to $530,907 from $813,817 at year-end 2025. The company remains a shell with no business operations, funding ongoing costs from IPO proceeds held in trust.

• · The company is a shell company (blank check) with no business operations, classified as an emerging growth company and non-accelerated filer.
• · Redeemable ordinary shares (11.5M) are carried at redemption value of $10.25 per share at Jun 30, 2026, up from $10.07 at Dec 31, 2025.
• · Accretion of redeemable shares to redemption amount totaled $1,022,588 in Q1 2026 and $1,034,576 in Q2 2026, increasing accumulated deficit.
• · Total shareholders' deficit worsened to ($3,486,163) at Jun 30, 2026 from ($3,159,913) at Dec 31, 2025.
• · Net cash used in operating activities was $282,910 in H1 2026 vs. $0 in H1 2025.
• · Deferred underwriting fee of $4,025,000 remains unchanged from IPO.

14-08-2026

Figure Certificate Co. reported a net income of $155 for Q2 2026, a significant improvement from a net loss of ($790) in Q2 2025, driven by a surge in interest income to $5,060 from $35. However, for the first six months of 2026, the company posted a net loss of ($808), an improvement from a ($2,050) loss in the prior year period, but still negative. Total assets more than doubled to $562,000 from $329,803 at year-end 2025, primarily due to a large increase in certificate reserve liabilities.

• · The company's total certificate reserve liability grew to $557,494 from $328,796 at year-end 2025, driven by significant new certificate issuance to related parties ($539,420) and third parties ($443,747) during H1 2026.
• · Operating expenses paid by the Parent on behalf of the company were $1,018 for H1 2026, down from $1,340 in H1 2025.
• · The company had no income tax provision for any period presented.
• · Net cash provided by operating activities was $11,522 for H1 2026, compared to just $34 in H1 2025.
• · The company's accumulated deficit grew to ($4,483) as of June 30, 2026 from ($3,675) at year-end 2025.

14-08-2026

CIM Opportunity Zone Fund, L.P. reported a net loss attributable to the fund of $22,748 for Q2 2026 and $51,864 for H1 2026, compared to net income of $637 and $90,504 in the same periods of 2025. Total revenues grew 63% YoY to $42,496 in Q2 and 52% to $73,968 in H1, driven by strong solar and rental income. However, expenses more than doubled, particularly solar and property operating expenses, interest expense, and depreciation, leading to the swing to a net loss. Total assets increased to $3,741,790 from $3,491,628 at year-end 2025, while partners' capital declined to $136,381 from $189,392.

• · Real estate and solar facilities under development more than doubled to $641,400 from $276,549 at year-end 2025.
• · Notes payable increased 38.3% to $708,891 from $512,758, with a weighted average market interest rate of 7.8% (down from 8.3% at year-end 2025).
• · Net cash used in operating activities was $21,685 in H1 2026 vs $538 in H1 2025.
• · Net cash used in investing activities was $240,164 in H1 2026 vs $99,772 in H1 2025, driven by additions to real estate.
• · Net cash provided by financing activities was $155,316 in H1 2026 vs net cash used of $3,863 in H1 2025, primarily from $238,920 in notes payable borrowings.
• · Distributions and redemptions paid totaled $73,590 in H1 2026 vs $8,936 in H1 2025.
• · Redeemable partners' capital decreased to $2,581,365 from $2,629,868 at year-end 2025.
• · Retained earnings deficit widened to ($709,743) from ($657,872) at year-end 2025.

14-08-2026

BM Acquisition Corp. (BMOK) filed its 10-Q for the quarter ended June 30, 2026, reporting a net loss of $4,000 for the three-month period and $29,081 for the six-month period. The company remains a pre-revenue SPAC with $25,000 in cash, total assets of $660,003, and a shareholders' deficit of $92,269, primarily due to accumulated losses and a related-party promissory note of $752,272. No operating or financing cash flows were generated during the period.

• · Deferred offering costs increased from $590,001 at December 31, 2025 to $635,003 at June 30, 2026.
• · Accrued offering costs were $0 at June 30, 2026, down from $50,325 at December 31, 2025.
• · Promissory note – a related party increased from $627,864 at December 31, 2025 to $752,272 at June 30, 2026.
• · Basic and diluted net loss per ordinary share was $(0.00) for the three months ended June 30, 2026, $(0.02) for the six months ended June 30, 2026, and $(0.03) for the period from May 27, 2025 (Inception) through June 30, 2025.
• · Total shareholders' deficit worsened from $(63,188) at December 31, 2025 to $(92,269) at June 30, 2026, driven by accumulated deficit of $(117,269).

14-08-2026

SPACSphere Acquisition Corp. (SSAC) reported net income of $687,454 for Q2 2026 and $1,335,802 for H1 2026, driven by interest earned on trust account securities, compared to a net loss of $28,197 in the prior-year period (inception to June 30, 2025). The company completed its IPO and over-allotment in early 2026, raising $172.5 million in trust, but continues to report operating losses ($847,965 in Q2 2026) and a significant accumulated deficit of $12,632,215 as of June 30, 2026. The company's shareholders' deficit deepened to $12,631,535 from $85,178 at year-end 2025, reflecting the accretion of Class A shares to redemption value.

• · The company completed its IPO and full over-allotment exercise in February 2026, raising $172.5 million in trust.
• · Deferred underwriting fee payable of $12,075,000 as of June 30, 2026.
• · Basic and diluted net income per share for both Class A and Class B ordinary shares was $0.03 for Q2 2026 and $0.07 for H1 2026.
• · The company had $229,394 in cash equivalents as of June 30, 2026, up from $6,081 at December 31, 2025.
• · Net cash used in operating activities was $350,588 for H1 2026.

14-08-2026

Amcor plc reported FY2026 net sales of $23,506M, up 56.6% from $15,009M in FY2025, driven by the acquisition of Berry Global. Net income attributable to Amcor surged to $1,106M from $511M, a 116.4% increase, and diluted EPS rose to $2.38 from $1.60. However, SG&A expenses increased 60.2% to $1,931M, and amortization of acquired intangibles more than doubled to $558M, reflecting integration costs and acquisition-related charges.

• · Restructuring, transaction and integration expenses, net, decreased to $298M in FY2026 from $307M in FY2025, a 2.9% decline.
• · Interest expense increased to $676M in FY2026 from $396M in FY2025, a 70.7% increase.
• · Income tax expense increased to $181M in FY2026 from $135M in FY2025, a 34.1% increase.
• · The filing includes a PCAOB ID 1358 for the independent registered public accounting firm.
• · The report covers items from Part I through Part IV, including Risk Factors, Cybersecurity, Legal Proceedings, and Executive Compensation.

14-08-2026

Yinfu Gold Corp. reported a net loss of $28,493 for the three months ended June 30, 2026, compared to a net loss of $22,360 in the same period last year, a 27.4% increase in losses. The company generated no revenue in either period, while total operating expenses rose 6.8% to $32,735. Cash and cash equivalents increased to $2,720 from $822 at the start of the period, but the company's accumulated deficit deepened to $(2,968,125) and total comprehensive loss widened to $(48,862) from $(27,692).

• · The company had zero revenue for the third consecutive quarter (Q1 FY27 and Q1 FY26).
• · General and administrative expenses increased 27.2% YoY to $25,988 from $20,438.
• · Professional fees decreased 34.0% YoY to $6,747 from $10,219.
• · Other income decreased 28.3% YoY to $5,950 from $8,297.
• · Income tax expense of $1,708 was recorded in Q1 FY27 versus $0 in Q1 FY26.
• · Foreign currency translation loss widened to $20,369 from $5,332, a 282% increase.
• · Net cash provided by operating activities was $20,629 in Q1 FY27, compared to net cash used of $17,903 in Q1 FY26.
• · Borrowing from third parties increased 367% to $78,134 as of June 30, 2026 from $16,718 as of March 31, 2026.
• · The company has an accumulated deficit of $2,968,125 and total stockholders' deficit of $684,035.
• · Related party transactions include advances and repayments with entities controlled by key individuals.

14-08-2026

Nevada Canyon Gold Corp. reported a net loss of $874,602 for the six months ended June 30, 2026, an improvement from a net loss of $1,247,387 in the same period of 2025. However, the quarterly net loss widened to $550,735 from $365,117 in Q2 2025, driven by a sharp increase in exploration expenses and new director and officer compensation. Cash decreased to $4,922,840 from $5,455,294 at year-end 2025, and working capital declined to $3,524,746 from $4,100,734.

• · Mineral property and royalty interests increased slightly to $2,815,395 from $2,775,395 at year-end 2025.
• · Accumulated deficit grew to $13,329,733 from $12,455,131 at December 31, 2025.
• · No investing or financing cash flows occurred in the first half of 2026, compared to $80,000 provided by investing and $288,149 provided by financing in the same period of 2025.
• · Director and officer compensation of $257,658 was recorded in the first half of 2026, compared to $116,667 in the prior year period.
• · Warrants outstanding remained flat at 124,994 with a weighted average exercise price of $1.20.

14-08-2026

Yubo International Biotech Ltd reported zero revenue for both the three and six months ended June 30, 2026 and 2025, with net losses widening slightly in Q2 2026 to $268,721 from $249,722 in Q2 2025. Total assets declined to $672,272 from $847,094 at year-end 2025, while total liabilities increased to $3,327,598 from $2,791,297, deepening the shareholders' deficit to $2,655,327. The company continues to rely on related-party advances to fund operations, with cash on hand of only $11,989.

• · Revenue remained at $0 for all periods presented; no sales of products or services were recorded.
• · Operating expenses decreased to $238,860 in Q2 2026 from $249,699 in Q2 2025, a decline of 4.3%.
• · Employee compensation fell to $165,491 in Q2 2026 from $183,864 in Q2 2025, a decrease of 10.0%.
• · Depreciation and amortization dropped sharply to $793 in Q2 2026 from $41,744 in Q2 2025, a decline of 98.1%.
• · Other operating expenses swung to $43,806 in Q2 2026 from $(29,032) in Q2 2025, a negative variance of $72,838.
• · Accumulated deficit grew to $8,260,616 as of June 30, 2026 from $7,740,059 at December 31, 2025.
• · Net cash used in operating activities improved to $291,261 in H1 2026 from $406,071 in H1 2025, a reduction of 28.3%.
• · The company had no investing or financing cash flows from external sources; all financing came from related-party advances.
• · The VIE structure shows total liabilities of $4,460,544 against total assets of $2,058,467 as of June 30, 2026, indicating negative equity of $2,402,077.
• · The company's ability to continue as a going concern is uncertain given minimal cash and recurring losses.